View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Michiel Declercq
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi
 PRESS RELEASE

Mithra enters into exclusive negotiations with Gedeon Richter and secu...

Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of , Mithra has selected the offer submitted by Gedeon Richter, which relates to Estetra SRL, Neuralis SA and specific assets held by Mithra R&D SA related to the E4 platform, as a basis for further negotiations and decided to grant exclusivity to Gedeon Richter for the purpose of such negotiation...

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update May 2024 : Adding Fugro, Removing Arcadis

In this May edition of our Dynamic Top Pick List we replace Arcadis by Fugro. Arcadis continues to deliver consistently on its promises and is working hard to realise its 2026 margin targets via cross selling, leveraging its global engineering platform and numerous self-help measures. In spite of this we remove Arcadis from our Dynamic Top Pick List as the recent & strong share price performance leaves little room for further short term triggers As a service provider to the energy industry, Fu...

 PRESS RELEASE

Mithra updates on offers received in the context of its monetization p...

Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023 Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process. As it stands, the aggregate amount of these offers is insufficient to ensure full repayment of all creditors of Mithra, and, therefore, the offers do not allow to create value for Mithra’s shareholders at the present time.Mithra has requested the suspension of trading of its shares on Euronext Brussels pending continuing negotiations with offering parties.Mithra postpones...

 PRESS RELEASE

Mithra secures court protection measures to advance monetization proce...

Mithra secures court protection measures to advance monetization process Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing Organization.Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra's complex therapeutics business.Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company's commitment to maximizing ...

Jacob Mekhael ... (+3)
  • Jacob Mekhael
  • Thibault Leneeuw
  • Thomas Vranken
Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update April 2024: Adding TINC

We continue our KBC Securities Dynamic Top Pick List with a 50/50 cyclical/defensive selection, but with a focus on value stocks that have been left behind. Defensive segment like holdings are overweight. However, in the Benelux we have a selection of cyclical industrials at cheap valuations that have often underperformed the market. We favour Benelux value stocks as even a mild recession typically hits growth stocks proportionally harder. We notice that some stocks have been hit hard by minor s...

 PRESS RELEASE

Celyad Oncology publie ses résultats financiers pour l'année 2023 ains...

MONT-SAINT-GUIBERT, Belgique--(BUSINESS WIRE)-- Regulatory News: Celyad Oncology (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (la “Société”), annonce aujourd'hui ses résultats financiers pour l'année 2023 au 31 décembre 2023 et présente une mise à jour de ses activités. Michel Lussier, Chief Executive Officer par intérim de Celyad Oncology, commente : “ Au cours des deux dernières années, Celyad Oncology a opéré un changement stratégique important, avec l'ambition de rester à la pointe de l'innovation dans le domaine de l'immunothérapie et plus précisément des thérapies à base de lymphocytes...

Hilde Van Boxstael ... (+9)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Morning Notes : AED BB, BFIT NA, EURN BB, HAL NA, IVA FP, MITRA BB, SE...

: AED BB, BFIT NA, EURN BB, HAL NA, IVA FP, MITRA BB, SEQUA BB, TESB BB, AZE BB, FAST NA

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Delen acquires Box Consultants, doubles AuM in Netherlands. IBA: 2H23 preview. IMCD: Another step in Latin America. Staffing: Dutch period 2 - Feb 24 volume, revenue trends weaker on tougher comps

Jacob Mekhael ... (+4)
  • Jacob Mekhael
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Wim Hoste
Kris Kippers
  • Kris Kippers

Ackermans & van Haaren - Interesting acquisition Delen + add-on in Van...

• Bank Delen announced the acquisition of Box Consultants in the Netherlands which is rumoured to double the firm's AuM in the Netherlands while also adding some high profile Dutch families to its client base• AvH also announced a EUR 41m add-on investment in the Van Moer family, hereby raising its stake to 32.4%• These two investments will likely be well-received by the market. Some investors wished for more dynamic in the investment portfolio combined with higher ticket sizes. Both invest...

Guy Sips ... (+6)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi
Thomas Vranken
  • Thomas Vranken

Mithra FY23: better than expected operations, but cash and liabilities...

Mithra's FY23 results reveal € 40m revenues and € -48m REBITDA somewhat higher than our expectations, although a € 74m impairment on the CMO and Zoreline tanks the net loss to € 173.5m. While the monetisation process for (parts of) the business is ongoing, we estimate that little value could be left for shareholders. We therefore adopt a Sell rating (previously Reduce) and decrease our TP from € 1.0 to € 0.1.

Guy Sips ... (+11)
  • Guy Sips
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List Update March 2024 : Replacing UCB by Tubize

We replace UCB by Tubize in our KBC Securities Dynamic Top Pick List. Over the past few weeks, UCB has seen a strong rally in its share price, markedly outperforming the BEL-20 index. The rally came on the back of renewed investor confidence in its flagship product Bimzelx, which gained FDA approval for psoriasis in October 2023 albeit with unexpected warnings and precautions. In the meantime, we see that commercial traction is growing in line with our expectations, as phyicians and caregivers ...

Sharad Kumar S.P
  • Sharad Kumar S.P

Holdings Report - February 2024 KBCS Holdings Universe Underperforms B...

1M Performance - Absolute: Over the last 1M period, the KBCS Holdings Universe posted a return of -3.8% which was mainly driven by single-asset holdings (-5.4%) while multi-asset holdings posted a less negative return og -2.8%. The 3 top performers during the period were Financière de Tubize (+8.7%), Whitestone Group (+7.7%), and Texaf (+3.0%) while the 3 worst performers were Heineken Holding (-8.3%), Compagnie Du Bois Sauvage (-7.7%), and Solvac (-7.5%). YTD Performance - Relative: On a YTD ...

Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Thibault Leneeuw
  • Thomas Vranken
Thomas Vranken
  • Thomas Vranken

Mithra Dismantling process initiated

Mithra initiates the process to monetise its assets or sell its business with a 60-day bridge loan facility to fund the process. The appointment of CEO David H. Solomon was terminated, while CFO and COO take over as co-CEOs.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch